Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pelthos Therapeutics (PTHS) Net Margin (2024 - 2025)

Pelthos Therapeutics has reported Net Margin over the past 2 years, most recently at 131.29% for Q4 2025.

  • Quarterly results put Net Margin at 131.29% for Q4 2025, down 54585.0% from a year ago — trailing twelve months through Dec 2025 was 181.23% (down 761160.0% YoY), and the annual figure for FY2025 was 257.93%, changed.
  • Net Margin for Q4 2025 was 131.29% at Pelthos Therapeutics, up from 219.25% in the prior quarter.
  • Over the last five years, Net Margin for PTHS hit a ceiling of 121784.57% in Q2 2025 and a floor of 50230.2% in Q2 2024.